|
nasdaq:sgen
|
10683536
|
Apr 14th, 2024 12:00AM
|
Cascadian Therapeutics, Inc.
|
646
|
13.00
|
Open
|
|
Apr 13th, 2024 11:41PM
|
Apr 13th, 2024 11:41PM
|
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.
|
Open
|
|
Open
|
2601 Fourth Avenue
|
Seattle
|
Washington
|
US
|
98121
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
21407
|
Apr 14th, 2024 12:00AM
|
Seagen
|
96K
|
2037
|
Open
|
|
Apr 13th, 2024 11:41PM
|
Apr 13th, 2024 11:41PM
|
Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer.
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care.
We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community.
Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future.
Seagen social media accounts, including this page, will no longer be active or monitored. Please follow Pfizer https://www.linkedin.com/company/pfizer/ for new content!
|
Open
|
Antibody-Drug Conjugates, Conjugation Chemistry, Monoclonal antibody-based therapies for cancer, Cancer drug development, Drug development, Blood cancers, Bladder cancer, Hodgkin lymphoma, and Non-Hodgkin lymphoma
|
Open
|
21823 30th Dr SE
|
Bothell
|
Washington
|
US
|
98021
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
21407
|
Apr 13th, 2024 12:00AM
|
Seagen
|
96K
|
2043
|
Open
|
|
Apr 12th, 2024 11:33PM
|
Apr 13th, 2024 12:06PM
|
Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer.
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care.
We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community.
Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future.
Seagen social media accounts, including this page, will no longer be active or monitored. Please follow Pfizer https://www.linkedin.com/company/pfizer/ for new content!
|
Open
|
Antibody-Drug Conjugates, Conjugation Chemistry, Monoclonal antibody-based therapies for cancer, Cancer drug development, Drug development, Blood cancers, Bladder cancer, Hodgkin lymphoma, and Non-Hodgkin lymphoma
|
Open
|
21823 30th Dr SE
|
Bothell
|
Washington
|
US
|
98021
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
10683536
|
Apr 13th, 2024 12:00AM
|
Cascadian Therapeutics, Inc.
|
646
|
13.00
|
Open
|
|
Apr 12th, 2024 11:33PM
|
Apr 13th, 2024 12:06PM
|
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.
|
Open
|
|
Open
|
2601 Fourth Avenue
|
Seattle
|
Washington
|
US
|
98121
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
21407
|
Apr 12th, 2024 12:00AM
|
Seagen
|
96K
|
2050
|
Open
|
|
Apr 11th, 2024 11:39PM
|
Apr 12th, 2024 09:02AM
|
Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer.
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care.
We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community.
Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future.
Seagen social media accounts, including this page, will no longer be active or monitored. Please follow Pfizer https://www.linkedin.com/company/pfizer/ for new content!
|
Open
|
Antibody-Drug Conjugates, Conjugation Chemistry, Monoclonal antibody-based therapies for cancer, Cancer drug development, Drug development, Blood cancers, Bladder cancer, Hodgkin lymphoma, and Non-Hodgkin lymphoma
|
Open
|
21823 30th Dr SE
|
Bothell
|
Washington
|
US
|
98021
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
10683536
|
Apr 12th, 2024 12:00AM
|
Cascadian Therapeutics, Inc.
|
645
|
13.00
|
Open
|
|
Apr 11th, 2024 11:39PM
|
Apr 12th, 2024 09:02AM
|
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.
|
Open
|
|
Open
|
2601 Fourth Avenue
|
Seattle
|
Washington
|
US
|
98121
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
21407
|
Apr 11th, 2024 12:00AM
|
Seagen
|
96K
|
2051
|
Open
|
|
Apr 11th, 2024 12:17AM
|
Apr 11th, 2024 11:47AM
|
Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer.
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care.
We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community.
Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future.
Seagen social media accounts, including this page, will no longer be active or monitored. Please follow Pfizer https://www.linkedin.com/company/pfizer/ for new content!
|
Open
|
Antibody-Drug Conjugates, Conjugation Chemistry, Monoclonal antibody-based therapies for cancer, Cancer drug development, Drug development, Blood cancers, Bladder cancer, Hodgkin lymphoma, and Non-Hodgkin lymphoma
|
Open
|
21823 30th Dr SE
|
Bothell
|
Washington
|
US
|
98021
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
10683536
|
Apr 11th, 2024 12:00AM
|
Cascadian Therapeutics, Inc.
|
643
|
13.00
|
Open
|
|
Apr 11th, 2024 12:17AM
|
Apr 11th, 2024 11:47AM
|
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.
|
Open
|
|
Open
|
2601 Fourth Avenue
|
Seattle
|
Washington
|
US
|
98121
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
21407
|
Apr 10th, 2024 12:00AM
|
Seagen
|
96K
|
2051
|
Open
|
|
Apr 9th, 2024 11:41PM
|
Apr 10th, 2024 05:54PM
|
Seagen is now part of Pfizer! Together with our Pfizer colleagues, we will continue our mission of bringing life-saving treatments to people living with cancer.
Our scientific leadership and world-leading antibody-drug conjugate (ADC) technology combined with the scale and strength of Pfizer's capabilities and expertise, will help position Pfizer at the forefront of innovation in cancer care.
We are so proud of our employees for the work that has been done over the past 25 years to positively impact the cancer community.
Check out the announcement https://lnkd.in/dfq7V-tw to join us in our excitement for the future.
Seagen social media accounts, including this page, will no longer be active or monitored. Please follow Pfizer https://www.linkedin.com/company/pfizer/ for new content!
|
Open
|
Antibody-Drug Conjugates, Conjugation Chemistry, Monoclonal antibody-based therapies for cancer, Cancer drug development, Drug development, Blood cancers, Bladder cancer, Hodgkin lymphoma, and Non-Hodgkin lymphoma
|
Open
|
21823 30th Dr SE
|
Bothell
|
Washington
|
US
|
98021
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
nasdaq:sgen
|
10683536
|
Apr 10th, 2024 12:00AM
|
Cascadian Therapeutics, Inc.
|
643
|
13.00
|
Open
|
|
Apr 9th, 2024 11:41PM
|
Apr 10th, 2024 05:54PM
|
Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in developing innovative therapeutic product candidates for the treatment of cancer. Our goal is to discover, develop and commercialize novel compounds that have the potential to improve the lives and outcomes of cancer patients. Our most advanced product candidate is ONT-380, an orally active and selective small molecule HER2 inhibitor. We are headquartered in Seattle, Washington. For more information, visit www.cascadianrx.com.
|
Open
|
|
Open
|
2601 Fourth Avenue
|
Seattle
|
Washington
|
US
|
98121
|
|
Seattle Genetics
|
Health Care
|
Pharmaceuticals & Biotechnology
|